Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Mayall

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Lancet (London, England)|April 11, 1981
Genetic variation that switches off and on beta-lactamase production by Haemophilus influenzaeS M Bell, D E Plowman, L J Burville, et al.
The Medical Journal of Australia|February 4, 1991
A case of Vibrio vulnificus septicaemia acquired in VictoriaE L Maxwell, B C Mayall, S R Pearson, et al.
Pathology|November 1, 1996
In vitro activity of meropenem compared to nine other antimicrobial agents: importance of its stability when used in agar dilution systemsU A Mudaliar, N I Furyk, V A Moritz, et al.
Journal of Medical Microbiology|May 1, 1993
Detection of Clostridium difficile enterotoxin gene in clinical specimens by the polymerase chain reactionH S Boondeekhun, V Gurtler, M L Odd, et al.
International Journal of Systematic and Evolutionary Microbiology|June 20, 2001
Nocardia veterana sp. nov., isolated from human bronchial lavageV Gürtler, R Smith, B C Mayall, et al.
The Medical Journal of Australia|January 5, 2002
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycinP B Ward, P D Johnson, E A Grabsch, et al.
Pathology|December 5, 1998
An Australian isolate of Mycobacterium shimoideiR J Goudge, B C Mayall, D E Leslie, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSAK C Horne, B P Howden, E A Grabsch, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Lancet (London, England)|April 11, 1981
Genetic variation that switches off and on beta-lactamase production by Haemophilus influenzaeS M Bell, D E Plowman, L J Burville, et al.
The Medical Journal of Australia|February 4, 1991
A case of Vibrio vulnificus septicaemia acquired in VictoriaE L Maxwell, B C Mayall, S R Pearson, et al.
Pathology|November 1, 1996
In vitro activity of meropenem compared to nine other antimicrobial agents: importance of its stability when used in agar dilution systemsU A Mudaliar, N I Furyk, V A Moritz, et al.
Journal of Medical Microbiology|May 1, 1993
Detection of Clostridium difficile enterotoxin gene in clinical specimens by the polymerase chain reactionH S Boondeekhun, V Gurtler, M L Odd, et al.
International Journal of Systematic and Evolutionary Microbiology|June 20, 2001
Nocardia veterana sp. nov., isolated from human bronchial lavageV Gürtler, R Smith, B C Mayall, et al.
The Medical Journal of Australia|January 5, 2002
Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycinP B Ward, P D Johnson, E A Grabsch, et al.
Pathology|December 5, 1998
An Australian isolate of Mycobacterium shimoideiR J Goudge, B C Mayall, D E Leslie, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2009
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSAK C Horne, B P Howden, E A Grabsch, et al.
Pageof 2